These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 6670234)

  • 1. [Blood serum polyamines and their urinary excretion in malignant lymphoma].
    Draga NV; Berdinskikh NK; Kindzel'skiĭ LP; Zaletok SP; Usatenko VD
    Vrach Delo; 1983 Dec; (12):44-6. PubMed ID: 6670234
    [No Abstract]   [Full Text] [Related]  

  • 2. [Combined modality therapy of malignant lymphoma].
    Itami J; Arimizu N
    Nihon Rinsho; 1986 Feb; 44(2):433-8. PubMed ID: 3702069
    [No Abstract]   [Full Text] [Related]  

  • 3. [After-care of malignant lymphoma].
    Jorke D
    Schweiz Rundsch Med Prax; 1986 Jul; 75(28):847-9. PubMed ID: 2426753
    [No Abstract]   [Full Text] [Related]  

  • 4. [Malignant lymphomas].
    Rodríguez E
    Rev Enferm; 1985 Feb; 8(78):27-9. PubMed ID: 3845678
    [No Abstract]   [Full Text] [Related]  

  • 5. [Bulky mediastinal malignant lymphoma].
    Arai N; Nakata M; Shirai T
    Nihon Kyobu Shikkan Gakkai Zasshi; 1993 Jan; 31(1):26-31. PubMed ID: 8468817
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Conventional second-line salvage chemotherapy regimens are not warranted in patients with malignant lymphomas who have progressive disease after first-line salvage therapy regimens.
    Ardeshna KM; Kakouros N; Qian W; Powell MG; Saini N; D'Sa S; Mackinnon S; Hoskin PJ; Goldstone AH; Linch DC
    Br J Haematol; 2005 Aug; 130(3):363-72. PubMed ID: 16042685
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Lymphoma].
    Mohar A; Sobrevilla-Calvo P; Velasquez WS
    Rev Invest Clin; 1997 May; 49 Suppl 1():56-63. PubMed ID: 9380990
    [No Abstract]   [Full Text] [Related]  

  • 8. [Hematologic therapy of malignant lymphoma].
    Honetz N
    Wien Klin Wochenschr; 1971 Jul; 83(27):522-3. PubMed ID: 5123479
    [No Abstract]   [Full Text] [Related]  

  • 9. Classical Hodgkin's lymphoma presenting as a testicular mass: report of a case.
    Seliem RM; Chikwava K; Swerdlow SH; Young RH; Ferry JA
    Int J Surg Pathol; 2007 Apr; 15(2):207-12. PubMed ID: 17478785
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Controversies in therapy of malignant lymphomas].
    Diehl V; Engert A
    Internist (Berl); 1994 Apr; 35(4):313-22. PubMed ID: 8200756
    [No Abstract]   [Full Text] [Related]  

  • 11. [High dose chemotherapy followed by hematopoietic stem cell transplantation for malignant lymphoma].
    Tobinai K
    Gan To Kagaku Ryoho; 1995 Oct; 22(12):1724-30. PubMed ID: 7574802
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Malignant lymphoma: an update on diagnosis, staging, and management.
    Perlin E
    Prim Care; 1980 Sep; 7(3):409-22. PubMed ID: 6905202
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Long-term therapy in leukemias and malignant lymphomas].
    Aul C; Schneider W
    Fortschr Med; 1983 Feb; 101(7):275-82. PubMed ID: 6840654
    [No Abstract]   [Full Text] [Related]  

  • 14. [Malignant lymphoproliferative lesions of the trachea].
    Kharchenko VP; Galil-Ogly GA; Kuz'min IV; Lebedev VA; Gvarishvili AA; Sotnikov VM; Bershchanskaia AM
    Arkh Patol; 1998; 60(6):52-6. PubMed ID: 9949907
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Role of chemical cytostatic treatment in therapy of hemopathies producing chronic malignant conditions].
    INTROZZI P; MARINONE G
    Haematologica; 1953; 37(11):1195-1274. PubMed ID: 13151517
    [No Abstract]   [Full Text] [Related]  

  • 16. [Malignant lymphoma].
    Streuli RA
    Schweiz Rundsch Med Prax; 1981 May; 70(20):909-15. PubMed ID: 7015304
    [No Abstract]   [Full Text] [Related]  

  • 17. [Malignant lymphoma of the neck, nose and pharyngeal region].
    Cerny T
    Schweiz Rundsch Med Prax; 1993 Dec; 82(50):1447-51. PubMed ID: 8290837
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Care of the patient with malignant lymphoma.
    Hays K; Rafferty DC
    Nurs Clin North Am; 1982 Dec; 17(4):677-95. PubMed ID: 6817308
    [No Abstract]   [Full Text] [Related]  

  • 19. Phase I/II study of high-dose cyclophosphamide, etoposide and cisplatin followed by autologous bone marrow or peripheral blood stem cell transplantation in patients with poor prognosis Hodgkin's disease or non-Hodgkin's lymphoma.
    Klumpp TR; Mangan KF; Glenn LD; Malaspina DR; Cropper T; Mullaney M; Macdonald JS
    Bone Marrow Transplant; 1993 Oct; 12(4):337-45. PubMed ID: 7506091
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ifosfamide, etoposide, cytarabine, and dexamethasone as salvage treatment followed by high-dose cyclophosphamide, melphalan, and etoposide with autologous peripheral blood stem cell transplantation for relapsed or refractory lymphomas.
    Schütt P; Passon J; Ebeling P; Welt A; Müller S; Metz K; Moritz T; Seeber S; Nowrousian MR
    Eur J Haematol; 2007 Feb; 78(2):93-101. PubMed ID: 17313557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.